首页> 外文期刊>Journal of Crystal Growth >Pharmaceutical cocrystals: a comparison of sulfamerazine with sulfamethazine
【24h】

Pharmaceutical cocrystals: a comparison of sulfamerazine with sulfamethazine

机译:药物共晶体:柳氮磺胺嘧啶与柳氮磺胺嘧啶的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Although there has been much debate about its definition among scientists, a cocrystal may be defined as a crystalline material that consists of two or more electrically neutral molecular species held together by non-covalent forces, and meanwhile all components are solids at room temperature. Obviously it is great to introduce predictable structural motifs to an active pharmaceutical ingredient (API) by design. One widely used approach to cocrystal design is based on the consideration of ApKa, which can represent the propensity of molecular species to form a cocrystal or a salt. In this work, p-aminobenzoic acid (PABA) was mixed with sulfamerazine (SMZ) or sulfamethazine (STH) by use of neat cogrinding and solvent-drop cogrinding. It was found that PABA and SMZ with a △pKa of 2.13 would form a binary eutectic, while PABA and STH with a larger △pKa of 2.59 can form a cocrystal in the ratio of 1:1. The phenomenon indicates that not only the △pKa but also the stereo-hindrance effect (geometric fit) should be considered during the design of pharmaceutical cocrystals.
机译:尽管科学家之间关于其定义的争论一直很多,但共晶可以定义为一种晶体材料,它是由两个或多个通过非共价作用力保持在一起的电中性分子组成的,同时所有组分在室温下均为固体。显然,通过设计将可预测的结构基序引入活性药物成分(API)真是太好了。共晶设计的一种广泛使用的方法是基于对ApKa的考虑,它可以代表分子物种形成共晶或盐的倾向。在这项工作中,对氨基苯甲酸(PABA)与磺胺嘧啶(SMZ)或磺胺二甲嘧啶(STH)通过纯共研磨和溶剂滴共研磨进行混合。发现△pKa为2.13的PABA和SMZ将形成二元共晶,而△pKa较大的为2.59的PABA和STH可形成1:1的共晶。这种现象表明,在药物共晶体的设计过程中,不仅应考虑△pKa,而且还应考虑立体阻碍效应(几何拟合)。

著录项

  • 来源
    《Journal of Crystal Growth》 |2011年第1期|p.110-114|共5页
  • 作者单位

    School of Chemical & Material Engineering, Jiangnan University, Lihu Road #1800, Wuxi 214122, China;

    School of Chemical & Material Engineering, Jiangnan University, Lihu Road #1800, Wuxi 214122, China;

    School of Chemical & Material Engineering, Jiangnan University, Lihu Road #1800, Wuxi 214122, China;

    School of Chemical & Material Engineering, Jiangnan University, Lihu Road #1800, Wuxi 214122, China;

    Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Ont., Canada N6A 5B9;

    School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637459, Singapore;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    A1. characterization; A1. x-ray diffraction; A2. industria1 crysta1lization; B1. organic compounds;

    机译:A1。表征;A1。 X射线衍射;A2。工业结晶B1。有机化合物;
  • 入库时间 2022-08-17 13:18:25

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号